Petrelintide in people with liver impairment
Part of Digestive system clinical trials.
This trial tests how a drug called petrelintide is processed in people with different levels of liver function. It may help doctors understand how to dose the drug safely for patients with liver disease, including those with type 2 diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old
- Have a BMI between 18.5 and 40
- Have either a normal liver function or a stable liver impairment (Child-Pugh Grade A, B, or C) for at least 3 months
- If you have type 2 diabetes, your HbA1c should be 11% or lower and your treatment must be stable for 8 weeks
- Not be pregnant, breastfeeding, or planning to become pregnant, and use effective birth control if applicable
- No known allergy to petrelintide or related drugs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication called petrelintide to help people with overweight or obesity and heart disease lose weight. It may offer a new way to manage weight and improve heart health.
This study tests a new medication called petrelintide to see how well it helps people lose weight and improve their health. It's for adults with overweight or obesity who have struggled to lose weight with diet alone.
This trial tests a new medicine called eloralintide in people with healthy livers and in those with mild, moderate, or severe liver damage. It helps researchers learn how the liver affects the medicine in the body.
This study tests a new medicine called petrelintide to help people with excess weight and type 2 diabetes lose weight and improve blood sugar control. It may be an option if you've struggled with weight loss through diet alone.
This study checks how a new tablet moves through the body and if it is safe for people with mild or moderate liver problems compared to people with healthy livers. It might help doctors understand how to dose the drug for people like you.
This study tests a new combination of two medicines, petrelintide and enicepatide, given as a shot to help with weight loss in people who are overweight or have obesity. The goal is to find the best dose and see if it works well and is safe.
Hear when a new Impaired Hepatic Function trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.